Jin Rong Jie·2025-08-18 08:45Core Viewpoint - Shanghai Pharmaceuticals Holding Co., Ltd. is a major pharmaceutical group listed in both Shanghai and Hong Kong, focusing on innovation and health improvement [1] Group 1: Stock Performance - On August 18, the Shanghai Composite Index rose by 0.85%, closing at 3728.03 points, while the Hang Seng Index fell by 0.37%, closing at 25176.85 points [1] - Shanghai Pharmaceuticals' A-shares closed at 18.95 yuan, with an increase of 0.74%, while its H-shares closed at 12.67 Hong Kong dollars, decreasing by 0.39% [1] Group 2: Company Overview - Shanghai Pharmaceuticals is included in the Shanghai Stock Exchange 180 Index, the CSI 300 Index, and the Morgan Stanley China Index (MSCI) [1] - The company promotes core values of "innovation, integrity, cooperation, inclusiveness, and responsibility," aiming to enhance public health and become a respected leading brand in pharmaceutical manufacturing and health services [1] Group 3: Business Strategy - The company is committed to continuous innovation and has been increasing its investment in research and development to accelerate its transformation [1]